{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:27:24Z","timestamp":1790098044594,"version":"4.0.1"},"reference-count":96,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Impulse control disorders (ICDs) are frequent non-motor complications of Parkinson\u2019s disease (PD), usually related to dopaminergic therapy. Uric acid (UA) has been studied as a biomarker of PD severity and has been linked to impulsivity in non-PD populations. However, its association with ICDs in patients with PD (PwPs) has not been investigated. This study aimed to assess the relationship between serum UA levels, the uric acid to creatinine ratio (UA\/Cr), and ICD prevalence in PwPs. Materials and Methods: We enrolled 172 PwPs hospitalized for follow-up or treatment modification. ICDs were screened with the Questionnaire for Impulsive-Compulsive Disorders in Parkinson\u2019s Disease (QUIP). Clinical data included demographics, disease severity, motor and non-motor symptoms, and dopaminergic treatment. Fasting serum UA and UA\/Cr were determined. Results: ICDs were present in 24.42% of patients, most commonly binge eating and compulsive buying. PwPs with ICDs had longer disease duration, more motor complications, higher dopaminergic doses, and more frequent dopamine agonist use. No relationship was found between absolute UA and overall ICD occurrence. However, lower UA\/Cr was observed in patients with hypersexuality and pathological gambling, as well as in those with multiple ICD subtypes. Logistic regression confirmed that higher UA\/Cr reduced the odds of hypersexuality (OR = 0.55; 95% CI 0.31\u20130.98) and multiple ICDs (OR = 0.33; 95% CI 0.13\u20130.84). As a secondary finding, lower absolute UA was observed in PwPs with more advanced motor symptoms, motor complications, depressive symptoms, and cognitive impairment. Conclusions: Lower UA\/Cr was selectively associated with specific ICD subtypes and with the coexistence of multiple ICDs in patients with PD. UA\/Cr may serve as a marker of ICD heterogeneity. Confirmation in larger, prospective cohorts is needed to establish clinical relevance.<\/jats:p>","DOI":"10.3390\/medicina61101789","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:53:37Z","timestamp":1759492417000},"page":"1789","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Uric Acid and Impulse Control Disorders in Parkinson\u2019s Disease: A Cross-Sectional Analysis"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3693-9565","authenticated-orcid":false,"given":"Mateusz","family":"To\u015b","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7128-0444","authenticated-orcid":false,"given":"Agata","family":"Dymek","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Morka","sequence":"additional","affiliation":[{"name":"Regional Specialist Hospital No. 4 in Bytom, 41-902 Bytom, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"W\u0142odarczyk","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0340-660X","authenticated-orcid":false,"given":"Joanna","family":"Siuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ji, Z., Chen, Q., Yang, J., Hou, J., Wu, H., and Zhang, L. (2024). Global, regional, and national health inequalities of Alzheimer\u2019s disease and Parkinson\u2019s disease in 204 countries, 1990\u20132019. Int. J. Equity Health, 23.","DOI":"10.1186\/s12939-024-02212-5"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5603\/pjnns.103572","article-title":"Do Parkinson\u2019s Disease clinical subtypes really exist?","volume":"59","author":"Filidei","year":"2025","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Pfeiffer, R.F. (2016). Non-motor symptoms in Parkinson\u2019s disease. Park. Relat. Disord., 22.","DOI":"10.1016\/j.parkreldis.2015.09.004"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5603\/pjnns.104615","article-title":"Differences in prevalence of orthostatic hypotension between Parkinson\u2019s Disease motor subtypes","volume":"59","author":"Oikonomou","year":"2025","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bougea, A., and Angelopoulou, E. (2024). Non-Motor Disorders in Parkinson Disease and Other Parkinsonian Syndromes. Medicina, 60.","DOI":"10.3390\/medicina60020309"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Jucevi\u010di\u016bt\u0117, N., Balnyt\u0117, R., and Laucius, O. (2024). Exploring the Spectrum of Visual Illusions and Other Minor Hallucinations in Patients with Parkinson\u2019s Disease in Lithuania. Medicina, 60.","DOI":"10.3390\/medicina60040606"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Furdu-Lungu\u021b, E., Antal, C., Turcu, S., Costea, D.G., Mitran, M., Mitran, L., Diaconescu, A.S., Novac, M.B., and Gorecki, G.P. (2024). Study on Pharmacological Treatment of Impulse Control Disorders in Parkinson\u2019s Disease. J. Clin. Med., 13.","DOI":"10.3390\/jcm13226708"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhang, J.F., Wang, X.X., Feng, Y., Fekete, R., Jankovic, J., and Wu, Y.C. (2021). Impulse Control Disorders in Parkinson\u2019s Disease: Epidemiology, Pathogenesis and Therapeutic Strategies. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.635494"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00415-024-12865-5","article-title":"Impulse control disorders in Parkinson\u2019s disease: What\u2019s new?","volume":"272","author":"Marques","year":"2025","journal-title":"J. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1017\/S1041610220000253","article-title":"Excessive charity: A new aspect of impulse control disorders in Parkinson\u2019s disease?","volume":"32","author":"Abdulhakeem","year":"2020","journal-title":"Int. Psychogeriatr."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Augustine, A., Winstanley, C.A., and Krishnan, V. (2021). Impulse control disorders in parkinson\u2019s disease: From bench to bedside. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.654238"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lin, S.H., Lin, R.J., Chu, C.L., Chen, Y.L., and Fu, S.C. (2025). Associations Between Gut Microbiota Composition and Impulse Control Disorders in Parkinson\u2019s Disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136146"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neurol.2024.07.001","article-title":"Impulse control disorder: Review on clinical, pharmacologic, and genetic risk factors","volume":"180","author":"Leclercq","year":"2024","journal-title":"Rev. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5603\/pjnns.104405","article-title":"Parkinson\u2019s Disease and glucose dysregulation: Shared pathophysiological mechanisms and clinical implications","volume":"59","author":"Chmiela","year":"2025","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100074","DOI":"10.1016\/j.bionps.2023.100074","article-title":"Biomarkers in Parkinson\u2019s disease: A state of the art review","volume":"9","author":"Yamashita","year":"2023","journal-title":"Biomark. Neuropsychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/mds.29209","article-title":"Uric Acid in Parkinson\u2032s Disease: What Is the Connection?","volume":"37","author":"Seifar","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41531-022-00433-5","article-title":"Dose-response meta-analysis on urate, gout, and the risk for Parkinson\u2019s disease","volume":"8","author":"Chang","year":"2022","journal-title":"NPJ Park. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Otani, N., Hoshiyama, E., Ouchi, M., Takekawa, H., and Suzuki, K. (2023). Uric acid and neurological disease: A narrative review. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1164756"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1212\/WNL.0000000000002351","article-title":"Prospective study of plasma urate and risk of Parkinson disease in men and women","volume":"86","author":"Gao","year":"2016","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"D\u0103n\u0103u, A., Dumitrescu, L., Lefter, A., and Popescu, B.O. (2022). Serum Uric Acid Levels in Parkinson\u2019s Disease: A Cross-Sectional Electronic Medical Record Database Study from a Tertiary Referral Centre in Romania. Medicina, 58.","DOI":"10.3390\/medicina58020245"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/jcls.jcls_29_22","article-title":"Association of serum uric acid and non-motor symptoms in Parkinson\u2019s disease","volume":"19","author":"Odeniyi","year":"2022","journal-title":"J. Clin. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.parkreldis.2014.03.016","article-title":"Is serum uric acid related to non-motor symptoms in de-novo Parkinson\u2019s disease patients?","volume":"20","author":"Moccia","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"ref_23","first-page":"461","article-title":"The role of oxidative stress in parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Park. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ncpneuro0924","article-title":"Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis","volume":"4","author":"Henchcliffe","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1073\/pnas.1217296110","article-title":"Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration","volume":"110","author":"Chen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archneurol.2009.247","article-title":"Urate as a predictor of the rate of clinical decline in Parkinson disease","volume":"66","author":"Ascherio","year":"2009","journal-title":"Arch. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biopsych.2013.02.024","article-title":"Impulsivity is Associated with Uric Acid: Evidence from Humans and Mice","volume":"75","author":"Sutin","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2147\/NDT.S368471","article-title":"Association Between Serum Uric Acid Levels and Suicide Attempts in Adolescents and Young Adults with Major Depressive Disorder: A Retrospective Study","volume":"18","author":"Kong","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"To\u015b, M., Gra\u017cy\u0144ska, A., Antoniuk, S., and Siuda, J. (2024). Impulse Control Disorders in Parkinson\u2019s Disease and Atypical Parkinsonian Syndromes\u2014Is There a Difference?. Brain Sci., 14.","DOI":"10.3390\/brainsci14020181"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.24023","article-title":"Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s Disease-Rating Scale","volume":"27","author":"Weintraub","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.14740\/jocmr4079","article-title":"Serum Uric Acid, Serum Uric Acid to Serum Creatinine Ratio and Serum Bilirubin in Patients With Parkinson\u2019s Disease: A Case-Control Study","volume":"12","author":"Songsomboon","year":"2020","journal-title":"J. Clin. Med. Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Al-Daghri, N.M., Al-Attas, O.S., Wani, K., Sabico, S., and Alokail, M.S. (2017). Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-12085-0"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5603\/PJNNS.a2020.0049","article-title":"Validation of the Polish version of the Movement Disorder Society-Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS)","volume":"54","author":"Siuda","year":"2020","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"key":"ref_36","first-page":"71","article-title":"Charakterystyka psychometryczna polskiej adaptacji Kwestionariusza Depresji BDI-II Aarona T. Becka","volume":"19","author":"Zawadzki","year":"2009","journal-title":"Psychol. Etiol. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/apnr.2000.9231","article-title":"An examination of psychometric properties of the Mini-Mental State Examination and the standardized Mini-Mental State Examination: Implications for clinical practice","volume":"13","author":"Pangman","year":"2000","journal-title":"Appl. Nurs. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1468-1331.2008.02384.x","article-title":"Addenbrooke\u2019s Cognitive Examination validation in Parkinson\u2019s disease","volume":"16","author":"Reyes","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mds.29410","article-title":"Levodopa Dose Equivalency in Parkinson\u2019s Disease: Updated Systematic Review and Proposals","volume":"38","author":"Jost","year":"2023","journal-title":"Mov. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"To\u015b, M., Gra\u017cy\u0144ska, A., Antoniuk, S., and Siuda, J. (2023). Impulse Control Disorders in the Polish Population of Patients with Parkinson\u2019s Disease. Medicina, 59.","DOI":"10.3390\/medicina59081468"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","article-title":"ICARUS study: Prevalence and clinical features of impulse control disorders in Parkinson\u2019s disease","volume":"88","author":"Antonini","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00415-019-09692-4","article-title":"Dynamics of impulsive\u2013compulsive behaviors in early Parkinson\u2019s disease: A prospective study","volume":"267","author":"Svetel","year":"2020","journal-title":"J. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2024-334116","article-title":"Impulse control disorders in Parkinson\u2019s disease: A national Swedish registry study on high-risk treatments and vulnerable patient groups","volume":"96","author":"Wolfschlag","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e16144","DOI":"10.1111\/ene.16144","article-title":"Dopamine agonist serum concentrations and impulse control disorders in Parkinson\u2019s disease","volume":"31","author":"Staubo","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","article-title":"Asymptomatic hyperuricaemia: A silent activator of the innate immune system","volume":"16","author":"Joosten","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Teleanu, D.M., Niculescu, A.G., Lungu, I.I., Radu, C.I., Vlad\u00e2cenco, O., Roza, E., Cost\u0103chescu, B., Grumezescu, A.M., and Teleanu, R.I. (2022). An Overview of Oxidative Stress, Neuroinflammation and Neurodegenerative Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23115938"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","article-title":"Oxidative stress: A concept in redox biology and medicine","volume":"4","author":"Sies","year":"2015","journal-title":"Redox Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/13510002.2022.2046423","article-title":"Role of mitochondrial reactive oxygen species in homeostasis regulation","volume":"27","author":"Zhang","year":"2022","journal-title":"Redox Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10522-023-10050-1","article-title":"Aging, oxidative stress and degenerative diseases: Mechanisms, complications and emerging therapeutic strategies","volume":"24","author":"Chaudhary","year":"2023","journal-title":"Biogerontology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2013.07.005","article-title":"Oxidative stress in blood in Alzheimer\u2019s disease and mild cognitive impairment: A meta-analysis","volume":"59","author":"Schrag","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12964-024-01965-4","article-title":"Targeting uric acid: A promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"23","author":"Xu","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e38947","DOI":"10.1097\/MD.0000000000038947","article-title":"Association between high uric acid and the risk of Parkinson\u2019s disease: A meta-analysis","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1136\/bmjopen-2013-003620","article-title":"Low uric acid levels in patients with Parkinson\u2019s disease: Evidence from meta-analysis","volume":"3","author":"Shen","year":"2013","journal-title":"BMJ Open"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/aje\/kwm127","article-title":"Plasma urate and risk of Parkinson\u2019s disease","volume":"166","author":"Weisskopf","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/01.ATV.0000027524.86752.02","article-title":"Peroxidase properties of extracellular superoxide dismutase role of uric acid in modulating in vivo activity","volume":"22","author":"Hink","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/hmg\/ddi308","article-title":"Molecular pathogenesis of Parkinson\u2019s disease","volume":"14","author":"Gandhi","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mds.22139","article-title":"Uric acid in Parkinson\u2019s disease","volume":"23","author":"Schlesinger","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Chang, K.H., and Chen, C.M. (2020). The role of oxidative stress in Parkinson\u2019s disease. Antioxidants, 9.","DOI":"10.3390\/antiox9070597"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., and Jackson-Lewis, V.R. (2015). Oxidative stress and Parkinson\u2019s disease. Front. Neuroanat., 9.","DOI":"10.3389\/fnana.2015.00091"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/ane.12295","article-title":"Uric acid relates to dopamine transporter availability in Parkinson\u2019s disease","volume":"131","author":"Moccia","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4103\/aian.aian_647_21","article-title":"Assessment of non-motor symptoms of Parkinson\u2019s disease and their impact on the quality of life: An observatiobnal study","volume":"25","author":"Kumar","year":"2022","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1038\/s41598-021-88651-4","article-title":"Cross-sectional analysis of the Parkinson\u2019s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life","volume":"11","author":"Sauerbier","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"106088","DOI":"10.1016\/j.clineuro.2020.106088","article-title":"Comparative analysis of non-motor symptoms in patients with Parkinson\u2019s Disease and atypical parkinsonisms","volume":"197","author":"Antoniuk","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Gra\u017cy\u0144ska, A., Adamczewska, K., Antoniuk, S., Bie\u0144, M., To\u015b, M., Kufel, J., Urba\u015b, W., and Siuda, J. (2021). The influence of serum uric acid level on non-motor symptoms occurrence and severity in patients with idiopathic parkinson\u2019s disease and atypical parkinsonisms\u2014A systematic review. Medicina, 57.","DOI":"10.3390\/medicina57090972"},{"key":"ref_67","first-page":"1003","article-title":"Serum Uric Acid Levels and Non-Motor Symptoms in Parkinson\u2019s Disease","volume":"10","author":"Taddei","year":"2020","journal-title":"J. Park. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10072-021-05558-8","article-title":"Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson\u2019s disease","volume":"43","author":"Shi","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"396","DOI":"10.5603\/pjnns.105278","article-title":"Validation of the Polish version of the Movement Disorder Society Non-motor Rating Scale (MDS-NMS)","volume":"59","author":"Siuda","year":"2025","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpsychires.2016.07.007","article-title":"Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis","volume":"81","author":"Bartoli","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Lyngdoh, T., Bochud, M., Glaus, J., Castelao, E., Waeber, G., Vollenweider, P., and Preisig, M. (2013). Associations of serum uric acid and SLC2A9 variant with depressive and anxiety disorders: A population-based study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076336"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clinbiochem.2011.10.010","article-title":"Serum uric acid levels and the clinical characteristics of depression","volume":"45","author":"Wen","year":"2012","journal-title":"Clin. Biochem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e209699","DOI":"10.1212\/WNL.0000000000209699","article-title":"Long-Term Dementia Risk in Parkinson Disease","volume":"103","author":"Gallagher","year":"2024","journal-title":"Neurology"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"\u00c5str\u00f6m, D.O., Simonsen, J., Raket, L.L., Sgarbi, S., Hellsten, J., Hagell, P., Norlin, J.M., Kellerborg, K., Martinez-Martin, P., and Odin, P. (2022). High risk of developing dementia in Parkinson\u2019s disease: A Swedish registry-based study. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-21093-8"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Hendriks, M., Vinke, S., Berlot, R., Benedi\u010di\u010d, M., Jahansahi, M., Tro\u0161t, M., and Georgiev, D. (2024). In Parkinson\u2019s disease dopaminergic medication and deep brain stimulation of the subthalamic nucleus increase motor, but not reflection and cognitive impulsivity. Front. Neurosci., 18.","DOI":"10.3389\/fnins.2024.1378614"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Angelopoulou, E., Bougea, A., Hatzimanolis, A., Stefanis, L., Scarmeas, N., and Papageorgiou, S. (2024). Mild Behavioral Impairment in Parkinson\u2019s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects. Medicina, 60.","DOI":"10.3390\/medicina60010115"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ene.12533","article-title":"Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson\u2019s disease","volume":"22","author":"Moccia","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000342483","article-title":"Serum Uric Acid in Patients with Parkinson\u2019s Disease and Vascular Parkinsonism: A Cross-Sectional Study","volume":"20","author":"Pan","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2018.05.010","article-title":"Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson\u2019s disease: PALS study","volume":"55","author":"Huang","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1176\/appi.ajp.158.11.1783","article-title":"Psychiatric Aspects of Impulsivity","volume":"158","author":"Barratt","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5152\/NeuropsychiatrInvest.2021.05-017","article-title":"The Correlation Between Serum Uric Acid Level and Certain Clinical Variables in Antisocial Personality Disorder Patients","volume":"59","author":"Yildiz","year":"2022","journal-title":"Neuropsychiatr. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5455\/bcp.20160222092414","article-title":"Relationship Between Impulsivity and Plasma Uric Acid Levels in Patients with Substance Use Disorders Relationship between impulsivity and plasma uric acid levels in patients with substance use disorders","volume":"26","author":"Nurmedov","year":"2016","journal-title":"Bull. Clin. Psychopharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.evolhumbehav.2020.09.006","article-title":"Fructose and uric acid as drivers of a hyperactive foraging response: A clue to behavioral disorders associated with impulsivity or mania?","volume":"42","author":"Johnson","year":"2021","journal-title":"Evol. Hum. Behav."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"106026","DOI":"10.1016\/j.neubiorev.2025.106026","article-title":"Impulse control in Parkinson\u2019s disease: Distinct effects between action and choice","volume":"169","author":"Warden","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Criaud, M., Anton, J.L., Nazarian, B., Longcamp, M., Metereau, E., Boulinguez, P., and Ballanger, B. (2021). The human basal ganglia mediate the interplay between reactive and proactive control of response through both motor inhibition and sensory modulation. Brain Sci., 11.","DOI":"10.3390\/brainsci11050560"},{"key":"ref_86","first-page":"572743","article-title":"Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson\u2019s disease: Implications for cognitive function","volume":"2011","author":"MacDonald","year":"2011","journal-title":"Park. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"112395","DOI":"10.1016\/j.bbr.2019.112395","article-title":"You do not have to act to be impulsive: Brain resting-state activity predicts performance and impulsivity on the Balloon Analogue Risk Task","volume":"379","author":"Gentili","year":"2020","journal-title":"Behav. Brain Res."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kapsomenakis, A., Kasselimis, D., Vaniotis, E., Bougea, A., Koros, C., Simitsi, A.M., Stefanis, L., and Potagas, C. (2023). Frequency of Impulsive-Compulsive Behavior and Associated Psychological Factors in Parkinson\u2019s Disease: Lack of Control or Too Much of It?. Medicina, 59.","DOI":"10.3390\/medicina59111942"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/13685538.2017.1420158","article-title":"Levels of uric acid in erectile dysfunction of different aetiology","volume":"21","author":"Barassi","year":"2018","journal-title":"Aging Male"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Chen, W., Song, W., Zhang, H., Su, X., Chen, J., and Chen, J. (2025). Potential links between serum uric acid levels and testosterone levels in adult males: A cross-sectional study. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-97352-1"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Wan, H., Zhang, K., Wang, Y., Chen, Y., Zhang, W., Xia, F., Zhang, Y., Wang, N., and Lu, Y. (2020). The Associations Between Gonadal Hormones and Serum Uric Acid Levels in Men and Postmenopausal Women With Diabetes. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00055"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"de Oliveira, L.F.G., Souza-Junior, T.P., Fechio, J.J., Gomes-Santos, J.A.F., Sampaio, R.C., Vardaris, C.V., Lambertucci, R.H., and de Barros, M.P. (2022). Uric Acid and Cortisol Levels in Plasma Correlate with Pre-Competition Anxiety in Novice Athletes of Combat Sports. Brain Sci., 12.","DOI":"10.3390\/brainsci12060712"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jad.2014.12.031","article-title":"High serum uric acid level in adolescent depressive patients","volume":"174","author":"Tao","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","article-title":"Hyperuricemia and endothelial function: From molecular background to clinical perspectives","volume":"278","author":"Maruhashi","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/15257770802257952","article-title":"Inactivation of nitric oxide by uric acid","volume":"27","author":"Gersch","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/10715762.2012.747677","article-title":"Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production","volume":"47","author":"Klinke","year":"2013","journal-title":"Free Radic. Res."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1789\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:18:18Z","timestamp":1759493898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":96,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["medicina61101789"],"URL":"https:\/\/doi.org\/10.3390\/medicina61101789","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]}}}